Adamantem Capital
Adamantem Capital is a Sydney-based private capital firm founded in 2016. Its platform includes a buyout strategy for established mid-market businesses and an environmental opportunities strategy focused on high-growth operating businesses and environmental themes.
What stands out about Adamantem Capital
Adamantem Capital publicly describes two investment strategies: buyout investments in established mid-market businesses across consumer, business services, and healthcare, and environmental opportunities investments focused on clean energy and electrification, natural capital and abatement, and the circular economy. Its investment activity is focused on Australia and New Zealand.[1][2][3][4][7][8][9][10]
What does Adamantem Capital invest in?
Adamantem Capital is a Sydney-based private capital firm founded in 2016. Its investment platform includes a buyout strategy and an environmental opportunities strategy.
Adamantem’s homepage publicly states 17 platform investments, 25+ add-on acquisitions, and $2B+ in assets under management.[1][3]
The buyout strategy targets established mid-market businesses in Australia and New Zealand. The environmental opportunities strategy focuses on clean energy and electrification, natural capital and abatement, and the circular economy.
Adamantem states that integrated investment, portfolio operations, and sustainability teams work alongside management teams from day one. It identifies organic growth, strategic M&A, strategic capital investment, and operational improvements as value-creation levers.[2][4]
Owners evaluating a financial buyer can compare the offer with independent valuation analysis, understand how acquirers approach transactions through Auxo’s buy-side M&A process guide, and consider whether a full or partial sale best fits their objectives.
What should a business owner evaluate before considering a transaction with Adamantem Capital?
Owners evaluating Adamantem can clarify which fund and strategy would apply, how the opportunity would be assessed against the firm’s established mid-market or high-growth operating-business descriptions, and whether the proposed investment would involve a platform or add-on path. Adamantem’s stated model includes management partnership, organic growth, strategic M&A, strategic capital investment, operational improvements, and sustainability integration.[2][4]
What revenue, EBITDA, enterprise-value, and equity-investment parameters apply to the specific opportunity
Does Adamantem seek majority control, minority positions, or both for this opportunity
What companies does Adamantem Capital target?
The buyout strategy is described as targeting established mid-market businesses. The environmental opportunities strategy targets high-growth operating businesses.
Adamantem’s Strategies page does not state a universal minimum or maximum investment size, revenue or EBITDA threshold, or required equity contribution.[2]
Adamantem’s buyout strategy names consumer, business services, and healthcare as target sectors. Its environmental opportunities strategy names clean energy and electrification, natural capital and abatement, and the circular economy.[2]
Adamantem states that its investment platform and local networks are focused on Australia and New Zealand. The firm identifies Sydney as its base.[1]
Adamantem’s homepage publicly states 17 platform investments and 25+ add-on acquisitions. Its active portfolio pages identify investments including Heritage Lifecare, Zenitas, Hellers, Climate Friendly, NAK Hair, Advara HeartCare, Retail Zoo, Ecoware, Evnex, Edge Zero, QANTM, Microgrid, Mason Stevens, Nexon, Solar Battery Group, Stand, and Apiam Animal Health.[3][5][6]
Adamantem’s active portfolio pages identify Heritage Lifecare, Zenitas, Hellers, Climate Friendly, NAK Hair, Advara HeartCare, Retail Zoo, Ecoware, Evnex, Edge Zero, QANTM, Microgrid, Mason Stevens, Nexon, Solar Battery Group, Stand, and Apiam Animal Health.[5][6]
Adamantem completed its investment into PF Olsen and Forest360 in March 2026, creating an independent forestry manager in Australasia backed by its Environmental Opportunities Fund. It completed its acquisition of Apiam Animal Health in February 2026 and its acquisition of a majority stake in Solar Battery Group in February 2026. In December 2025, it completed its acquisition of a majority stake in Nexon Asia Pacific. Adamantem had announced an agreement to acquire a majority stake in Nexon Asia Pacific in August 2025.[7][8][9][10][11]
What is not clear from Adamantem Capital's public investment criteria?
Adamantem’s Strategies page does not state a universal minimum or maximum investment size, revenue or EBITDA threshold, or required equity contribution.
The PF Olsen and Forest360, Apiam Animal Health, Solar Battery Group, and Nexon completion releases do not disclose transaction consideration or purchase-price amounts.[2][7][8][9][10]
Questions to ask when evaluating Adamantem Capital as a buyer or investment partner
Which fund and strategy would apply to the opportunity?
What revenue, EBITDA, enterprise-value, and equity-investment parameters apply to the specific opportunity?
Does Adamantem seek majority control, minority positions, or both for this opportunity?
What management rollover and retention expectations would apply?
How would add-on acquisitions be financed and governed?
What ownership duration and exit approach would apply to the specific investment?
Sources & research notes
- Official website / firm overview
- Investment strategy
- Transaction size / criteria
- Investment approach
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Structure / regulatory context
- Structure / regulatory context
How this profile was researched
Auxo profiles are prepared from publicly available primary and authoritative sources and reviewed for entity identity, factual support and disclosure consistency. When a fact cannot be supported by the reviewed public record, the profile identifies it as something to confirm directly rather than inferring it.
Independent research profile
This profile was prepared by Auxo Capital Advisors from publicly available information believed to be reliable and is provided solely for informational and educational purposes. It is not an endorsement, recommendation, ranking, solicitation, or representation regarding the profiled firm, its services, qualifications, transaction experience, regulatory status, financial condition, or suitability for any particular person, company, transaction, or investment.
Information obtained from third-party and public sources may be incomplete, inaccurate, outdated, or subject to change, and Auxo Capital Advisors makes no representation or warranty, express or implied, as to its accuracy, completeness, or timeliness. Readers should conduct their own independent diligence and consult appropriate professional advisers before engaging any advisor, intermediary, investor, lender, acquirer, or other transaction counterparty.
Broker-dealer and securities disclosure
Auxo Capital Advisors is an affiliate of Weild & Co., Member FINRA | SIPC. Securities-related activities and securities transactions are conducted through Weild & Co.
Nothing contained on this page constitutes an offer to sell, an offer to purchase, or a solicitation of an offer to buy or sell any security, investment product, or financial instrument. Nothing on this page constitutes investment advice, a recommendation regarding any security, or a recommendation to enter into any transaction with the profiled firm or any other party.
Any securities transaction, capital-raising engagement, investment-banking engagement, or other securities-related activity involving Auxo Capital Advisors or Weild & Co. is subject to applicable regulatory requirements, internal review and approval, suitability and other applicable diligence requirements, and the terms of a separate written engagement or transaction agreement, as applicable.
Inclusion of a third-party firm in this directory does not imply affiliation with, sponsorship by, endorsement by, or any other relationship with Auxo Capital Advisors or Weild & Co. unless expressly stated otherwise.